Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...
Vivani Medical (Nasdaq:VANI) announced today that it successfully administered the first GLP-1 implant in its LIBERATE-1 ...
NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...
I’m trying to lose the 18 pounds I have gained since the pandemic. It has been hard enough that I’m wondering about Ozempic.
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Vivani Medical (VANI) announced the successful administration of its first GLP-1 or exenatide, implant in the LIBERATE-1 clinical trial. This ...
Local law enforcement officers could soon be allowed to use Marine Corps Camp Blaz firing range and the old Yigo raceway for training, according to discussions during the latest meeting of the ...
This month pharmacies will no longer be allowed to sell lower-cost compounded versions of the anti-obesity drug tirzepatide — ...
CAIRO (AP) — The United Nations’ food agency says it has paused aid distribution in Sudan’s famine-hit Zamzam displacement camp of a half-million people as fighting intensifies between the ...
The global G-protein coupled receptors market size surpassed US$ 3.86 in 2024, rise to US$ 4.06 billion in 2025, and is expected to hit around US$ 6.37 billion by 2034. The market is growing at a CAGR ...
With the rising global obesity epidemic and the increasing demand for effective weight-loss treatments, the biopharma industry faces mounting pressure to revolutionize GLP-1 manufacturing to meet ...
I will be particularly interested in the company’s plan to attract and retain weight loss subscribers in the coming absence of popular GLP-1 compounds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results